Royal Bank of Canada

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 24,810
Total Value: 350517986000
Accession Number: 0001140361-25-019231
Form Type: 13F-HR
CIK: 0001000275
Manager Name: Royal Bank of Canada

Data Enrichment

78% identified

19,259 identified5,551 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

24,810 positions • $350,517,986K total value

24,810 positions

Manager:

SEC FilingSEC DataHachi Filing

Search and click to pin securities to the top

Page 331 of 331

Sort by:

GALECTIN THERAPEUTICS INC

Shares:

544(-70.5%)

Value:

$0(-100.0%)

XWELL, Inc.

Shares:

1(+0.0%)

Value:

$0

PLATINUM GROUP METALS LTD

Shares:

307(+10.4%)

Value:

$0

Gabelli Global Small & Mid Cap Value Trust

Shares:

25(-99.6%)

Value:

$0(-100.0%)

TNF Pharmaceuticals, Inc.

Shares:

60(+900.0%)

Value:

$0

Instrument	Shares		Other Manager	Value
Galectin Therapeutics Inc(GALTcusip363225202)	544	QoQ -70.48% (-1.3K) YoY NEW(+544)	All Managers (Combined)	$0	QoQ EXITED(-$3.0K) YoY NEW(+$0)
Xwell, Inc.(XWELcusip98420U802)	1	QoQ 0.00% (+0) YoY -99.36% (-156)	All Managers (Combined)	$0	QoQ -(+$0) YoY -(-$0)
Platinum Group Metals Ltd(PLGcusip72765Q882)	307	QoQ +10.43% (+29) YoY -97.40% (-11.5K)	All Managers (Combined)	$0	QoQ -(+$0) YoY EXITED(-$14.0K)
Gabelli Global Small & Mid Cap Value Trust(GGZcusip36249W104)	25	QoQ -99.63% (-6.8K) YoY -96.79% (-756)	All Managers (Combined)	$0	QoQ EXITED(-$80.0K) YoY EXITED(-$9.0K)
Tnf Pharmaceuticals, Inc.(TNFAcusip62856X201)	60	QoQ +900.00% (+54) YoY -24.05% (-19)	All Managers (Combined)	$0	QoQ -(+$0) YoY -(-$0)